Comprehensive Inflammatory Bowel Disease (IBD) Blood Panel
Comprehensive Inflammatory Bowel Disease (IBD) Panel (Labcorp)
This panel includes 5 tests that can aid in diagnosing Inflammatory Bowel Disease (IBD). IBD is an immune disease that is characterized by chronic inflammation of the GI tract. IBD typically refers to either Crohn's Disease or Ulcerative Colitis. Crohn's can affect any part of the GI tract but typically affects the small intestine. Ulcerative Colitis typically affects the large intestine. The 2 disorders usually cause similar symptoms which can include diarrhea, abdominal pain, blood in the stool, unexplained weight loss, and fatigue. Symptoms can come and go depending on whether the disease is active or in remission. People with a family history of IBD are more likely to develop the condition themselves. Identifying and differentiating between Crohn's Disease and Ulcerative Colitis can help ensure that a person receives proper treatment. The IBD panel combines several tests for a higher level of sensitivity and specificity than individual tests can provide.
This panel includes:
- Antichitobioside carbohydrate antibodies (ACCA)
- antilaminaribioside carbohydrate antibodies (ALCA)
- antimannobioside carbohydrate antibodies (AMCA)
- anti-Saccharomyces cerevisiae antibodies (gASCA)
- atypical perinuclear antineutrophil cytoplasmic antibody (pANCA)
These tests are typically ordered when a person has symptoms of IBD, especially if they have family members who have also been diagnosed. Test results should be interpreted by a person's doctor and further testing may be necessary to make a positive diagnosis. A Basic IBD Profile is also available.
Turnaround for this test is typically 5-8 business days.
Where can I find an Inflammatory Bowel Disease Profile, Comprehensive near me?
Check our lab finder to locate a collection site in your area.